• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions.

作者信息

Krieger Elizabeth, Toor Amir Ahmed

机构信息

Department of Pediatrics, Virginia Commonwealth University, Richmond, VA, United States.

Department of Internal Medicine, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.

出版信息

Front Immunol. 2020 Apr 28;11:777. doi: 10.3389/fimmu.2020.00777. eCollection 2020.

DOI:10.3389/fimmu.2020.00777
PMID:32425947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7212371/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/54a80641b96c/fimmu-11-00777-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/0b1b75c6ebf6/fimmu-11-00777-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/f38d1283827e/fimmu-11-00777-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/54a80641b96c/fimmu-11-00777-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/0b1b75c6ebf6/fimmu-11-00777-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/f38d1283827e/fimmu-11-00777-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7b/7212371/54a80641b96c/fimmu-11-00777-g0003.jpg

相似文献

1
Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions.移植物抗白血病效应能否与移植物抗宿主病分离？比例研究。
Front Immunol. 2020 Apr 28;11:777. doi: 10.3389/fimmu.2020.00777. eCollection 2020.
2
Natural regulation of immunity to minor histocompatibility antigens.对次要组织相容性抗原免疫反应的自然调节。
J Immunol. 2007 Mar 15;178(6):3558-65. doi: 10.4049/jimmunol.178.6.3558.
3
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies.运用新策略从移植物抗宿主病中剖析移植物抗白血病作用
Tissue Antigens. 2013 Apr;81(4):183-93. doi: 10.1111/tan.12090.
4
Enhancing graft-versus-leukemia after transplant: the rise of anti-cancer vaccines.增强移植后的移植物抗白血病效应：抗癌疫苗的兴起。
Front Biosci (Landmark Ed). 2012 Jan 1;17(2):635-55. doi: 10.2741/3949.
5
Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantation.理解并增强造血干细胞移植后的移植物抗白血病效应。
Cancer Treat Res. 2009;144:187-208. doi: 10.1007/978-0-387-78580-6_8.
6
Hematopoietic stem cell transplantation and cellular therapy.造血干细胞移植和细胞疗法。
HLA. 2017 May;89(5):267-277. doi: 10.1111/tan.13005.
7
Cancer vaccines and T cell therapy.癌症疫苗与T细胞疗法。
Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S97-S101. doi: 10.1016/j.bbmt.2012.09.020. Epub 2012 Oct 3.
8
T-cell therapy of leukemia.白血病的T细胞疗法。
Cancer Control. 2002 Mar-Apr;9(2):114-22. doi: 10.1177/107327480200900204.
9
Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.杀伤细胞免疫球蛋白样受体基因型对韩国无关造血干细胞移植后急性移植物抗宿主病的影响。
Tissue Antigens. 2007 Apr;69 Suppl 1:114-7. doi: 10.1111/j.1399-0039.2006.762_9.x.
10
Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.次要组织相容性抗原作为移植物抗白血病反应的靶点。
Curr Opin Hematol. 2002 Nov;9(6):497-502. doi: 10.1097/00062752-200211000-00005.

引用本文的文献

1
Vitiligo and Alopecia Areata After Donor Lymphocyte Infusions in a Child With Relapsed Acute Myeloid Leukemia.一名复发性急性髓系白血病儿童接受供体淋巴细胞输注后出现白癜风和斑秃。
Cureus. 2024 Jan 23;16(1):e52810. doi: 10.7759/cureus.52810. eCollection 2024 Jan.
2
[Mechanism of relapse and its therapeutic strategies after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后的复发机制及其治疗策略]
Zhonghua Xue Ye Xue Za Zhi. 2021 Oct 14;42(10):869-877. doi: 10.3760/cma.j.issn.0253-2727.2021.10.014.

本文引用的文献

1
Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.非同义受者错配 HLA 呈递的计算分析表明其对异基因 HSCT 后慢性移植物抗宿主病风险的影响。
Front Immunol. 2019 Jul 16;10:1625. doi: 10.3389/fimmu.2019.01625. eCollection 2019.
2
Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.髓系肿瘤移植后复发的治疗：阿扎胞苷和供者淋巴细胞输注作为挽救性治疗。
Leuk Lymphoma. 2019 Nov;60(11):2733-2743. doi: 10.1080/10428194.2019.1605066. Epub 2019 May 3.
3
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia.
突变核仁磷酸蛋白 1 作为急性髓系白血病的免疫治疗靶点。
J Clin Invest. 2019 Feb 1;129(2):774-785. doi: 10.1172/JCI97482. Epub 2019 Jan 14.
4
Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.确定干细胞移植中抗原差异的 T 细胞反应的定量原则。
Front Immunol. 2018 Oct 11;9:2284. doi: 10.3389/fimmu.2018.02284. eCollection 2018.
5
Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.染色体 Y 编码抗原与性别错配干细胞移植中的急性移植物抗宿主病相关。
Blood Adv. 2018 Oct 9;2(19):2419-2429. doi: 10.1182/bloodadvances.2018019513.
6
Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project.基于 1000 基因组计划分析次要组织相容性抗原景观。
Front Immunol. 2018 Aug 16;9:1819. doi: 10.3389/fimmu.2018.01819. eCollection 2018.
7
Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens.计算建模和确认白血病相关的次要组织相容性抗原。
Blood Adv. 2018 Aug 28;2(16):2052-2062. doi: 10.1182/bloodadvances.2018022475.
8
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.异基因造血干细胞移植治疗骨髓增生异常综合征后无移植物抗宿主病、无复发生存。
Biol Blood Marrow Transplant. 2019 Jan;25(1):63-72. doi: 10.1016/j.bbmt.2018.08.004. Epub 2018 Aug 10.
9
SpliceRCA: Single-Cell Analysis of mRNA Splicing Variants.SpliceRCA：mRNA剪接变体的单细胞分析
ACS Cent Sci. 2018 Jun 27;4(6):680-687. doi: 10.1021/acscentsci.8b00081. Epub 2018 May 30.
10
Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.供者-受者杀伤细胞免疫球蛋白样受体（KIR）基因分型匹配对人类白细胞抗原（HLA）全相合同胞造血干细胞移植后的慢性移植物抗宿主病及复发率具有保护作用。
Ann Hematol. 2018 Jun;97(6):1027-1039. doi: 10.1007/s00277-018-3274-0. Epub 2018 Mar 16.